Early diagnosis of pancreatic cancer, time to screen high-risk individuals?

Minerva Gastroenterologica e Dietologica

Volumn 57, Issue 2, 2011, Pages 205-212

  Iglesias Garcia, J ^a   Larino Noia J ^a   Dominguez Munoz J E ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Early detection of cancer; Endoscopy; Pancreatic neoplasms; Risk factors

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN; CA 19-9 ANTIGEN; CATHEPSIN E; CYCLIN D2; MOLECULAR MARKER; PROTEIN P16; TELOMERASE; TUMOR MARKER;

CANCER SCREENING; CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; FAMILY HISTORY; GENE MUTATION; GENETIC RISK; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; EVIDENCE-BASED MEDICINE; HUMANS; MAGNETIC RESONANCE IMAGING; PANCREATIC NEOPLASMS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPAIN; SURVIVAL RATE;

EID: 79960639570     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008;6:275-82. (Pubitemid 351318383)
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer. J Clin 2005;55:10-30.
3. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancenan update. Dig Dis 2010;28:645-56.
4. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-583.
5. Furukawa H, Okada S, Saisho H, Ariyama J, Karasawa E, Nakaizumi A et al. Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer 1996;78:986-90. (Pubitemid 26284862)
6. Maitra A, Fukushima N, Takori K, Hruban RH. Precursors to invasive pancreatic cancer. Adv Anat Pathol 2005;12:81-91 (Pubitemid 40515796)
7. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ et al. Treatment and prevention of intraephitelial neoplasia:an important target for accelerated new agent developments. Clin Cancer Res 2002;8:314-46.
8. Steinberg WM, Barkin JS, Bradley EL 3rd, DiMagno E, Layer P, Canto MI et al. Should patients with strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas? Pancreas 2009;38.e137-150
9. Brand R, Lerch M, Rubinstein W, Neoptolemos JP, Whitcomb DC, Hruban RH et al. Advances in counseling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1440-69.
10. Lowenfels AB, Maissonneuve P, DiMagno EP, Elitsur Y, Gates LK Jr, Perrault J et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6. (Pubitemid 27136736)
11. Lowenfels AB, Maissoneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am 2000;84:565-73. (Pubitemid 30346152)
12. Giardiello Fm, Brensinger JD, Tersmette Ac, Goodman SN, Petersen GM, Booker S et al. Vary high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-53.
13. Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006;12:3209-15. (Pubitemid 43837371)
14. American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999;117:1463-84.
15. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with famdial pancreatitic cancer kindreds. Cancer Res 2004;64:2634-8.
16. Rulyak SJ, Lowenfels AB, Maissoneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003;124:1292-9. (Pubitemid 36531804)
17. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-87. (Pubitemid 38971421)
18. Wilentz RE, Iacobouzo-Donahue CA, Argani P, Mc-Carthy DM, Parsons JL, Yeo CJ et al. Loss of expression of DPC4 in pancreatic intraepithelial neoplasia: evidence that DPC 4 inactivation occurs late in neoplastic progression. Cancer Res 2000;60:2002-6. (Pubitemid 30207663)
19. Tanaka M. International Consensus Guidelines for the management of IPMN and MCN of the pancreas. Nippon Shokakybio Gakkai Zasshi 2007;104:1338-43.
20. Hruban RH, Adsay NB, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN et al. Pancreatic intraepithelial neoplasia:a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-86. (Pubitemid 32423354)
21. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C et al. Screening for early pancreatic neoplasia in high-risk individuals:a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-81. (Pubitemid 43825802)
22. Kinney T. Evidence-based imaging of pancreatic malignancies. Surg Clin North Am 2010;90:235-49.
23. D'Onofrio M, Galloti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev Med Devices 2010;7:257-73
24. Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K et al. Screening for pancreatic neoplasia in high-risk individuals:an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-21. (Pubitemid 38834045)
25. Bipat S, Phoa SS, van Delden OM, Bossuyt PM, Gouma DJ, Laméris JS et al. Ultrasonography, computed tomography and magnetic resonance for diagnosis and determining resectability of pancreatic adenocarcinomas meta-analysis. J Comput Assist Tomogr 2005;29:438-45. (Pubitemid 41060274)
26. Song SJ, Lee JM, Kim YJ, Kim SH, Lee JY, Han JK et al. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MRI imaging using ROC analysis. J Magn Reson Imaging 2007;26:86-93.
27. Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas:multi-detector row CT with curved reformations correlation with MRCP. Radiology 2006;238:560-9. (Pubitemid 43134368)
28. Canto M, Schulick R, Goggins M. Preoperative detection of familial pancreatic neoplasms by endoscopic ultrasonography (EUS), multidetector computed tomography (CT), and/or magnetic resonance cholangiopancreatography (MRCP). Gastrointest Endosc 2008;65:AB225
29. Iglesias-Garcia J, Lariño-Noia J, Dominguez-Muñoz JE. Endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. Rev Esp Enferm Dig 2009;101:631-8.
30. DeWitt J, Deveraux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 2006;4:717-25. (Pubitemid 43825805)
31. Irisawa A, Sato A, Sato M, Ikeda T, Suzuki R, Ohira H. Early diagnosis of small pancreatic cancer, role of endoscopic utrasonography. Dig Endosc 2009;21 (suppl 1):S92-96
32. Catanzaro A, Richarson S, Veloso H, Isenberg GA, Wong RC, Sivak MV Jr et al. Long-term follow-up of patients with clinical indeterminate suspicion of pancreatic cancer and normal EUS. Gastrointest Endosc 2003;58:836-40. (Pubitemid 37521651)
33. Seijo-Rios S, Lariño-Noia J, Iglesias-Garcia J, Lozano León A, Domínguez Muñoz JE. Intraductal papillary mucinous tumor:diagnostic and therapeutic approach. Gastroenterol Hepatol 2008;31:92-7.
34. Tanaka M, Chart S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
35. Tanaka K, Kida M. Role of Endoscopy in screening of early pancreatic cancer and bile duct cancer. Dig Endosc 2009;21 (suppl 1):S97-100
36. Vema EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD et al. Pancreatic cancer screening in a prospective cohort of high risk patients:a comprehensive strategy of imaging and genetics. Clin Cancer Res 2010;16:5028-37.
37. Kurtz RC, Simon J, Ludwig E. A pancreatic cancer screening program for familial high-risk individuals [abstract]. Gastroenterology 2007;132:A-199
38. Poley J, Kluijt I, Gouma D, Harinck F, Wagner A, Aalfs C et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009;104:2175-81.
39. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am. 2000;84:707-18. (Pubitemid 30346165)
40. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131:247-55.
41. Brune K, Abe T, Canto M, Klein AP, Maitra A, Volkan Adsay N et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006;30:1007-76.
42. Wiersema MJ, Hawes RH, Lehman GA, Kochman ML, Sherman S, Kopecky KK. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993;25:555-64. (Pubitemid 24002729)
43. Sahai AV, Zimmerman M, Aabakken L, Tarnasky PR, Cunningham JT, van Velse A et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998;48:18-25. (Pubitemid 28337423)
44. Meckler KA, Brentnall TA, Haggitt RC, Crispin D, Byrd DR, Kimmey MB et al. Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Pathol. 2001;25:1047-53. (Pubitemid 32685902)
45. Iglesias-García J, Domínguez-Muñoz JE. Endoscopic ultrasound-guided biopsy for the evaluation of pancreatic tumors. Gastroenterol Hepatol 2007;30:597-601.
46. Topazian M, Enders F, Kimmey M, Brand R, Chak A, Clain J et al. Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc. 2007;66:62-7. (Pubitemid 46970752)
47. Ogawa Y, Tanaka M, Inoue K, Yamaguchi K, Chijiiwa K, Mizumoto K et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer 2002;94:2344-9. (Pubitemid 34457114)
48. Lemoine NR. Molecular advances in pancreatic cancer. Digestion 1997;58:550-6. (Pubitemid 27515719)
49. Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H et al. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol 2000;15:1333-8.
50. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006;66:1208-17. (Pubitemid 43165992)
51. Rosty C, Goggins M. Early detection of pancreatic carcinoma. Hematol Oncol Clin North Am 2002;16:37-52.
52. Neglia JP, Fitzsimmons SC, Maisonneuve P, Schöni MH, Schöni-Affolter F, Corey M et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Eng J Med 1995;332:494-9.
53. Fernandez E, La Vecchia C, Porta M, Negri E, d'Avanzo B, Boyle P. Pancreatitis and the risk of pancreatic cancer. Pancreas 1995;11:185-9.
54. McFaul C, Greenhalf W, Earl J, Howes N, Neoptolemos JP, Kress R et al. Anticipation in familial pancreatic cancer. Gut 2006;55-252-8.